- Clinical Trials
- April 2025
- 280 Pages
Global
From €2646EUR$3,000USD£2,290GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1102EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1102EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1102EUR$1,250USD£954GBP
- Report
- August 2025
- 146 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Report
- January 2025
- 180 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1102EUR$1,250USD£954GBP
- Report
- July 2025
- 208 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Report
- July 2025
- 350 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- July 2025
- 350 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- June 2025
- 150 Pages
Global
From €2380EUR$2,699USD£2,061GBP
- Report
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Report
- June 2025
- 150 Pages
Global
From €2380EUR$2,699USD£2,061GBP
- Report
- June 2025
- 245 Pages
Global
From €4405EUR$4,995USD£3,814GBP
- Report
- July 2025
- 200 Pages
United States
From €2196EUR$2,490USD£1,901GBP
- Report
- March 2024
- 150 Pages
Global
From €5247EUR$5,950USD£4,543GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more